On May 8, abortion providers in Virginia, Montana and Kansas filed a federal lawsuit against the FDA seeking an order to maintain and expand access to mifepristone, one of two drugs commonly used for early abortion and miscarriage.

“It is critical that abortion providers and patients obtain certainty in light of the chaos that is currently surrounding mifepristone,” said Nancy Northup, president and CEO of the Center for Reproductive Rights, who filed the lawsuit.